Renal clear cell carcinoma (ccRCC) comprises over 75% of all renal tumors and arises in
the epithelial cells of the proximal convoluted tubule. Molecularly ccRCC is characterized by …

Recent advances in the understanding of basic pathological mechanisms in various
neurological diseases depend directly on the development of novel bioanalytical …

We present the first analytical approach to demonstrate the in situ imaging of metabolites
from formalin‐fixed, paraffin‐embedded (FFPE) human tissue samples. Using high …

Mass spectrometry imaging (MSI) is an emerging technology that is capable of map**
various biomolecules within their native spatial context, and performing spatial multiomics …

Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MALDI
MSI) has become a powerful tool with a high potential relevance for the analysis of …

Mass spectrometry imaging (MSI) is able to simultaneously record the distributions of
hundreds of molecules directly from tissue. Rapid direct tissue analysis is essential for MSI …

Matrix‐assisted laser desorption/ionization imaging mass spectrometry (MALDI IMS) is a
molecular imaging technology uniquely capable of untargeted measurement of proteins …

Formalin-fixed paraffin-embedded (FFPE) tissue represents the primary source of clinical
tissue and is routinely used in MALDI-MSI studies. However, it is not particularly suitable for …

Endocrine tumors derive from endocrine cells with high heterogeneity in function, structure
and embryology, and are characteristic of a marked diversity and tissue heterogeneity …

The application of innovative spatial proteomics techniques, such as those based upon
matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) …